Skip to main content

Table 3 Dose modifying factors a for quiescent tumor cells relative to the total tumor cell populations

From: The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

  Treatment  
<Net micronucleus frequency = 0.7>
γ-Rays only 1.85 (1.7-2.0)b
Neutrons only 1.05 (1.0-1.1)
BPAc (250 mg/kg) 1.5 (1.4-1.6)
BPA (500 mg/kg) 1.55 (1.45-1.65)
BPA (750 mg/kg) 1.6 (1.5-1.7)
BSHd (125 mg/kg) 1.2 (1.15-1.25)
BSH (250 mg/kg) 1.3 (1.2-1.4)
BSH (325 mg/kg) 1.4 (1.3-1.5)
  1. a; Radiation dose required to obtain the net normalized micronucleus frequency of 0.7 in the quiescent tumor cell population in relation to the radiation dose required to obtain a net normalized micronucleus frequency of 0.7 in total tumor cell population.
  2. b; 95% confidence limit.
  3. c; Boronophenylalanine-10B.
  4. d; Sodium mercaptododecaborate-10B.